Advisor Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Advisor Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Hold	1,804	–	–	﹤0.01%	4692
2019 Q3	$7K	Hold	1,804	–	–	﹤0.01%	4524
2019 Q2	$6K	Hold	1,804	–	–	﹤0.01%	4627
2019 Q1	$5K	Hold	1,804	–	–	﹤0.01%	4714
2018 Q4	$5K	Sell	1,804 -2,000	-53%	-$6.55K	﹤0.01%	4541
2018 Q3	$15K	Buy	3,804 +2,728	+254%	+$12.4K	﹤0.01%	4057
2018 Q2	$5K	Buy	1,076 +76	+8%	+$463	﹤0.01%	4407
2018 Q1	$5K	Hold	1,000	–	–	﹤0.01%	4438
2017 Q4	$8K	Hold	1,000	–	–	﹤0.01%	4229
2017 Q3	$10K	Hold	1,000	–	–	﹤0.01%	3987
2017 Q2	$11K	Hold	1,000	–	–	﹤0.01%	3880
2017 Q1	$8K	Hold	1,000	–	–	﹤0.01%	3921
2016 Q4	$7K	Hold	1,000	–	–	﹤0.01%	3800
2016 Q3	$5K	Hold	1,000	–	–	﹤0.01%	3917
2016 Q2	$5K	Buy	+1,000	New	+$5.55K	﹤0.01%	3803

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Advisor Group's ENZ Position: Q4 2019 in Review

Advisor Group held its Enzo Biochem, Inc. (ENZ) position steady in Q4 2019 at 1,804 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4692.

Advisor Group first reported a position in ENZ in Q2 2016 and has held it in 15 quarters since. The position peaked at $15K in Q3 2018. 81 funds tracked by Wall St. Rank hold ENZ as of Q4 2019.

Advisor Group held 1,804 shares of Enzo Biochem, Inc. worth $5K as of Q4 2019.
Advisor Group left its Enzo Biochem, Inc. share count unchanged in Q4 2019.
Enzo Biochem, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4692 holding.
Advisor Group first reported a position in Enzo Biochem, Inc. in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Enzo Biochem, Inc. position peaked at $15K in Q3 2018.
81 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.